A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...

The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...

Genentech, a member of the Roche Group (RHHBY), announced that the U.S. Food and Drug Administration has approved Susvimo ...

Roche (RHHBY) announced that the Food and Drug Administration has approved Susvimo 100 mg/mL for the treatment of diabetic macular edema, a ...

New York-based VJ Group announced the launch of its newest venture, VJ Bio, a biotech company dedicated to creating an ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help restore vision in individuals with multiple sclerosis (MS) and other ...

On his first day in office, President Donald Trump designated drug cartels as terrorist organizations ... in the Western Hemisphere, an old vision of American dominance over its neighbors.” ...

Last year, Pantheon Vision conducted two Pre-Submission meetings with the FDA review team for guidance on the initial stages of pre-clinical and clinical work supporting a Premarket Approval (PMA ...

Companies say they are working to update their products to comply with the Food and Drug Administration's decision Wednesday to ban the artificial food dye Red 3, after the agency said it was ...

The Food and Drug Administration on Thursday authorized marketing of 20 nicotine pouches — the first time the products have been greenlit by the agency. Nicotine pouches are tobacco-free sachets ...

SILVER SPRING, Md., Jan. 16, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration authorized the marketing of 20 ZYN nicotine pouch products through the premarket tobacco product ...